Company Medicamen Biotech Limited

MEDICAMEQ

INE646B01010

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Generic Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 11:17:55 16/05/2024 BST			5-day change	1st Jan Change
525.5 ^INR	+6.19%		+1.14%	-12.77%

02-12	Medicamen Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
2023	Medicamen Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	CI

Medicamen Biotech Limited is an India-based integrated pharmaceutical and life sciences solution provider company. The Company is engaged in manufacturing of diverse range of pharmaceutical products oral solids, oral liquids, ointment for non-oncology products range and also produces tablets, capsule/lyohilized/dry powder injections for oncology product range. It focuses on oncology therapeutics, and other generics. The Company manufactures a range of products, including tablets, capsules, liquid syrup, dry syrup, such as beta-lactum and non-beta lactum, and ointments. The Company primarily focuses on oncology therapeutics. It is also focused on other therapeutic areas, such as cardiology, central nervous system (CNS), diabetology and pain management. Its oncology products include Abiraterone acetate, Anastrozole, Bicalutamide, Bendmustine HCL, Bortezomib, Busulfan, Capecitabine, Cisplatin, Erlotinib HCL, Gefitinib, Imatinib mesylate, Lenalidomide, Letrozole, Melphalan, and Pazopanib.

Number of employees: 388

INR in Million	2022	Weight	2023	Weight	Delta
Pharmaceutical 100.0 %	1,154	100.0 %	1,409	100.0 %	+22.02%

INR in Million	2022	Weight	2023	Weight	Delta
India 100.0 %	1,154	100.0 %	1,409	100.0 %	+22.02%

Managers	Title	Age	Since
Rajesh Madan CEO	Chief Executive Officer	-	-
Pratap Singh Rawat DFI	Director of Finance/CFO	-	24/07/18
Aneek Gupta COO	Chief Operating Officer	-	-
Parul Choudhary CMP	Compliance Officer	-	11/02/18

Members of the board	Title	Age	Since
Sanjay Bansal BRD	Director/Board Member	59	21/12/93
Rajesh Madan CEO	Chief Executive Officer	-	-
Vimal Kumar Shrawat BRD	Director/Board Member	62	10/02/19
Rahul Bishnoi CHM	Chairman	59	30/12/15
Ashwani Kumar Sharma BRD	Director/Board Member	64	30/12/15
Arun Kumar BRD	Director/Board Member	83	-
Suresh Kumar Singh BRD	Director/Board Member	-	30/12/15
Sumita Dwivedi BRD	Director/Board Member	-	12/11/18
Sangeeta Bishnoi BRD	Director/Board Member	-	10/02/19
Ravi Kumar Bansal BRD	Director/Board Member	60	29/05/19

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	12,714,600	5,113,838 ( 40.22 %)	0	40.22 %

Name	Equities	%	Valuation
SHIVALIK RASAYAN LIMITED 43.21 %	5,466,095	43.21 %	38 M ₹
TOYOTA TSUSHO CORPORATION 10.59 %	1,340,000	10.59 %	9 M ₹
Sanjay Bansal 1.603 %	202,813	1.603 %	1 M ₹
Ginnerup Capital ApS 1.238 %	156,600	1.238 %	1 M ₹
Rajesh Madan 1.217 %	154,000	1.217 %	1 M ₹
Om Prakash Chugh 1.091 %	137,967	1.091 %	957 578 ₹
Government of India 0.8931 %	112,993	0.8931 %	784 243 ₹
Motilal Oswal Asset Management Co. Ltd. 0.000538 %	68	0.000538 %	472 ₹

Medicamen Biotech Ltd.

1506, Chiranjiv Tower 43 Nehru Place

110019, New Delhi

+91 11 4758 9500

http://www.medicamen.com

address Medicamen Biotech Limited(MEDICAMEQ)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Generic Pharmaceuticals

	1st Jan change	Capi.
MEDICAMEN BIOTECH LIMITED	-12.77%	75.41M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.98%	43.92B
OTSUKA HOLDINGS CO., LTD.	+24.56%	23.09B
SANDOZ GROUP AG	+19.25%	15.35B
CIPLA LIMITED	+14.03%	13.61B
ZYDUS LIFESCIENCES LIMITED	+46.40%	12.02B
ONO PHARMACEUTICAL CO., LTD.	-10.14%	7B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+13.88%	5.6B

Generic Pharmaceuticals